LANSDOWNE PARTNERS (UK) LLP - JUNO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
LANSDOWNE PARTNERS (UK) LLP ownership history of JUNO THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$379,000
-37.3%
20,1250.0%0.00%
-40.0%
Q3 2016$604,00020,1250.01%
Other shareholders
JUNO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Crestline Management, LP 25,948,799$1,132,937,000100.00%
Biomark Capital Management Co. LLC 1,602,562$70,465,00085.76%
Omega Fund Management, LLC 1,229,512$54,062,00030.09%
Clarius Group, LLC 218,942$9,626,0002.93%
BB BIOTECH AG 1,305,000$57,381,0001.62%
Casdin Capital, LLC 17,500$769,0000.68%
Rock Springs Capital Management LP 197,001$8,662,0000.66%
BENNETT LAWRENCE MANAGEMENT L L C/NY 38,850$1,708,0000.55%
ArrowMark Colorado Holdings LLC 383,749$16,873,0000.46%
SUFFOLK CAPITAL MANAGEMENT LLC 68,848$3,027,0000.38%
View complete list of JUNO THERAPEUTICS INC shareholders